Quinoline derivatives and quinazoline derivatives having azolyl group
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 1, 2007
Issued Date -
N/A
app pub date -
Jun 7, 2004
filing date -
Apr 27, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An object of the present invention is to provide compounds having potent antitumor activity. The compounds according to the present invention are compounds represented by formula (I) or pharmaceutically acceptable salts or solvates thereof: ##STR00001## wherein X and Z represent CH or N; Y represents O or S; R.sup.1, R.sup.2, and R.sup.3 represent H, alkoxy or the like; R.sup.4 represents H; R.sup.5, R.sup.6, R.sup.7, and R.sup.8 represent H, halogen, alkoxy or the like; R.sup.9 and R.sup.10 represent H, alkyl or the like; and R.sup.11 represents optionally substituted azolyl.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully